Patient satisfaction with after-hours care for an urgent problem is higher if provided by their own family physician or their physician’s after-hours clinic, compared with a walk-in clinic, the emergency department and telephone health advisory services.
The B.C. government has proclaimed October Foster Family Month in recognition of foster parents who open their homes and their hearts to children in need in communities all across the province, announced Children and Family Development Minister Tom Christensen.
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Naegleria is found in many freshwater lakes and rivers in the United States, particularly in southern tier states. Therefore, it is likely that a low risk of Naegleria infection will always be associated with swimming in warm freshwater lakes, rivers, and hot springs.
The US Department of Health and Human Services (HHS) announced the purchase of 18.75 million doses of BioThrax (Anthrax Vaccine Adsorbed, AVA) from Emergent Biodefense Operations of Lansing, Mich., at a total of $448 million.
HHS Secretary Mike Leavitt announced that more than 90 percent of Medicare beneficiaries in a stand-alone Part D prescription drug plan (PDP) will have access to at least one plan in 2008 with premiums lower than they are paying this year. The open enrollment period for 2008 begins Nov. 15th and ends Dec. 31st.
US health officials reported that an amoeba that typically lives in lakes and enters the body through the nose and attacks the brain has been linked to six deaths in the United States this year.
Six patients in the United Kingdom suffering from multiple sclerosis are having their own stem cells injected into them as an experiment to see whether this type of treatment can repair the neurological damage that causes MS.
A new type of non-invasive imaging test may help prevent heart attacks. Known as Low-Dose Coronary CT Angiogram (CTA), the test uses less radiation than conventional imaging tests and may help detect heart disease certain asymptomatic patients.
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.